Natural History of Friedreich's Ataxia: Heterogeneity of Neurological Progression and Consequences for Clinical Trial Design.
Christian RummeyLouise A CorbenMartin DelatyckiGeorge WilmotSub H SubramonyManuela CortiKhalaf BusharaAntoine DuquetteChristopher M GomezJ Chad HoyleRichard H RoxburghLauren SeebergerGrace YoonKatherine MathewsTheresa ZesiewiczSusan PerlmanDavid R LynchPublished in: Neurology (2022)
- Understanding of the diversity within Friedreich's ataxia populations and their patterns of functional decline provides an essential foundation for future clinical trial design including patient selection and facilitates the interpretation of the clinical relevance of progression detected in Friedreich's ataxia.